Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The high mobility group protein, HMGI-C

G Goodwin1

  • 1Section of Molecular Carcinogenesis, Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey, UK.

The International Journal of Biochemistry & Cell Biology
|September 2, 1998
PubMed
Summary

High mobility group protein I-C (HMGI-C) is crucial for embryonic growth, acting as a transcription factor. Its dysregulation is linked to tumors, suggesting therapeutic potential for sarcomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of digital cognitive behavioural therapy for symptoms of generalised anxiety disorder: a study protocol for a randomised controlled trial.

Trials·2020
Same author

Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls.

Molecular psychiatry·2017
Same author

The identification of a new HLA-DPB1 allele (*1302) in one family and the detection of a recombination event between the DR and the DQ regions in another Caucasian T1DGC family.

Tissue antigens·2009
Same author

Lithium versus antidepressants in the long-term treatment of unipolar affective disorder.

The Cochrane database of systematic reviews·2006
Same author

Folate for depressive disorders.

The Cochrane database of systematic reviews·2003
Same author

Valproate for acute mood episodes in bipolar disorder.

The Cochrane database of systematic reviews·2003

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • High mobility group protein I-C (HMGI-C) is a nuclear phosphoprotein with DNA-binding domains.
  • HMGI-C expression is cell-cycle regulated and its gene is rearranged in mesenchymal tumors.
  • Disruption of HMGI-C alleles in mice leads to a pygmy phenotype, indicating a role in growth.

Purpose of the Study:

  • To investigate the role of HMGI-C in cell growth, particularly during embryonic development.
  • To explore the potential of HMGI-C as a therapeutic target in sarcomas.

Main Methods:

  • Analysis of HMGI-C gene expression patterns.
  • Examination of HMGI-C gene rearrangements in tumors.
  • Phenotypic analysis of HMGI-C knockout mice.

Main Results:

  • HMGI-C expression is linked to cell-cycle regulation and embryonic development.
  • Gene rearrangements of HMGI-C are observed in mesenchymal tumors.
  • Mice lacking HMGI-C exhibit growth defects (pygmy phenotype).

Conclusions:

  • HMGI-C likely functions as an architectural transcription factor regulating embryonic cell growth genes.
  • The DNA-binding properties of HMGI-C suggest it could be a target for chemotherapeutic agents in sarcomas.

Related Experiment Videos